Publications by authors named "Matthew W Nelson"

Claim this Profile
A
A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm.
John L Jefferies, Alison K Spencer, Heather A Lau, Matthew W Nelson, Joseph D Giuliano

Orphanet J Rare Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quetiapine at high doses for the treatment of refractory schizophrenia.
Douglas L Boggs, Deanna L Kelly, Stephanie Feldman, Robert P McMahon, Matthew W Nelson

Schizophr Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galantamine-induced QTc prolongation.
Matthew W Nelson, Robert W Buchanan

J Clin Psychiatry· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia.
Robert R Conley, Deanna L Kelly, Matthew W Nelson, Charles M Richardson, Stephanie Feldman

Clin Neuropharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapeutic effects of galantamine on apathy in a schizophrenia patient.
David S Arnold, Richard B Rosse, Dwight Dickinson, Rhonda Benham, Stephen I Deutsch, Matthew W Nelson

J Clin Psychiatry· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
Matthew W Nelson, Rhonda R Reynolds, Deanna L Kelly, Robert R Conley

Clin Neuropharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis